Novel agent shows promise in treating the most aggressive type of breast cancer
A unique antibody drug conjugate (ADC), which delivers a high dose of a cancer-killing drug to tumor cells through a targeted antibody, has been found in a global phase 3 clinical study to nearly double the survival time ...
Apr 21, 2021
0
79